Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Detailed Funding Announcement Planned For One PCORI Research Area

This article was originally published in The Gray Sheet

Executive Summary

Although most of its upcoming research solicitations will be very broad, the Patient-Centered Outcomes Research Institute plans to provide a more detailed description of needed studies in one area: accelerating patient-centered outcomes research and methodological research.

You may also be interested in...



PCORI Chooses Initial Projects, With Minimal Device/Diagnostic Focus

Only four projects have a device- or diagnostic-related implication.

Patients Could Play A Role In PCORI Research Application Reviews – Exec Director Selby

The notion of patient engagement in the research process could extend so far as to include reviewing applications submitted to the Patient-Centered Outcomes Research Institute, Executive Director Joe Selby says.

PCORI Will Ask Research Funding Applicants To Include Ideas For Disseminating Results

Draft checklist would ask researchers for ideas on involving stakeholders, “engagement points” and ways to disseminate research results, indicating PCORI will ask researchers to think outside of their typical approaches such as journal publication or scientific meetings.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031048

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel